Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly change » significant change (Expand Search), significantly enhance (Expand Search), significant changes (Expand Search)
change decrease » change increases (Expand Search), change degree (Expand Search)
Showing 1,701 - 1,720 results of 6,596 for search '(( significant decrease decrease ) OR ( significantly change decrease ))~', query time: 0.39s Refine Results
  1. 1701
    Effect of addition of ZrO<sub>2</sub> density of perovskite structure.

    Effect of addition of ZrO<sub>2</sub> density of perovskite structure. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1702
    Measured parameters of the fabricated LZCM composites.

    Measured parameters of the fabricated LZCM composites. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1703
    2D and 3D AFM micrographs of fabricated samples (a) 5LZCM (b) 10LZCM (c) 15LZCM.

    2D and 3D AFM micrographs of fabricated samples (a) 5LZCM (b) 10LZCM (c) 15LZCM. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1704
    Effect of addition of ZrO<sub>2</sub> on Hardness of perovskite structure.

    Effect of addition of ZrO<sub>2</sub> on Hardness of perovskite structure. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1705
    Effect of the addition of ZrO<sub>2</sub> on DTS of the perovskite structure.

    Effect of the addition of ZrO<sub>2</sub> on DTS of the perovskite structure. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1706
    The weight percentage of ZrO<sub>2</sub> and MnO<sub>2</sub> in the fabricated composite.

    The weight percentage of ZrO<sub>2</sub> and MnO<sub>2</sub> in the fabricated composite. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1707
    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by gender, age standardized to the U.S. standard population.

    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by gender, age standardized to the U.S. sta... by Shiying Hao (659634)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1708
    XRD pattern of the fabricated LZCM composites.

    XRD pattern of the fabricated LZCM composites. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1709
    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021, age standardized to the U.S. standard population.

    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021, age standardized to the U.S. standard popu... by Shiying Hao (659634)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1710
    Monthly number of tests per 100,000 patients and the 95% confidence intervals (CIs) for the chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021.

    Monthly number of tests per 100,000 patients and the 95% confidence intervals (CIs) for the chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1711
    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by race/ethnicity, age standardized to the U.S. standard population.

    Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by race/ethnicity, age standardized to the... by Shiying Hao (659634)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1712
    Different steps of the fabrication process.

    Different steps of the fabrication process. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1713
    The comparisons of key properties for different ZrO<sub>2</sub>-doped fabricated composites.

    The comparisons of key properties for different ZrO<sub>2</sub>-doped fabricated composites. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1714
    Effect of ZrO<sub>2</sub> Addition on CTE.

    Effect of ZrO<sub>2</sub> Addition on CTE. by Md. Abu Daud (21485629)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1715
    Basic characteristics of the studies included.

    Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1716
    PRISMA flowchart of the article selection process.

    PRISMA flowchart of the article selection process. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1717
    List_of_studies_identified_31-JAN-2025.

    List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1718
    Forest plot showing the mean difference of global IQ level among pediatric brain cancer patients treated with either PT or XRT.

    Forest plot showing the mean difference of global IQ level among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1719
    Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT.

    Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1720
    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT.

    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: